Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sd Biosensor Inc. (137310:KRX), powered by AI.
Sd Biosensor Inc. is currently trading at ₩7,140. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sd Biosensor Inc. on Alpha Lenz.
Sd Biosensor Inc.'s P/E ratio is -1.7.
“Sd Biosensor Inc. trades at a P/E of -1.7 (undervalued) with modest ROE of -19.5%.”
Ask for details →Sd Biosensor Inc. is a biotechnology company renowned for developing in-vitro diagnostic products. These products play an essential role in the healthcare industry, aiding in the detection, diagnosis, and monitoring of diseases. The company's offerings span clinical chemistry, immunology, molecular diagnostics, and point-of-care testing tools. With its advanced diagnostics technologies, Sd Biosensor Inc. contributes significantly to improving healthcare outcomes by providing accurate and timely information to medical professionals. It serves a variety of sectors, including hospitals, clinics, labs, and research institutions. The company's diagnostics solutions are crucial for managing disease outbreaks, chronic illnesses, and personalized medicine, contributing to both public health and individual patient care. Since its establishment, Sd Biosensor has become a key player in the global diagnostics market, helping healthcare professionals make informed decisions through reliable test results.
“Sd Biosensor Inc. trades at a P/E of -1.7 (undervalued) with modest ROE of -19.5%.”
Ask for details →Sd Biosensor Inc. (ticker: 137310) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 576 employees. Market cap is $862.1B.
The current price is ₩7,140 with a P/E ratio of -1.68x and P/B of 0.37x.
ROE is -19.50% and operating margin is -11.39%. Annual revenue is $710.6B.